DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Modi S, Tsurutani J, Takahashi S. et al.
Safety and efficacy results from a phase 1 study of DS-8201a in patients with HER2 expressing breast cancers.

Cancer Res 2018;
78: Abstr.. PD3-07

Download Bibliographical Data

Search in:
Access: